TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors

被引:20
作者
Bumroongkit, Kanokkan [1 ]
Rannala, Bruce [2 ,3 ]
Traisathit, Patrinee [4 ]
Srikummool, Metawee [1 ]
Wongchai, Yannawan [1 ]
Kangwanpong, Daloroong [1 ]
机构
[1] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50202, Thailand
[2] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA
[3] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA
[4] Chiang Mai Univ, Fac Sci, Dept Stat, Chiang Mai 50202, Thailand
关键词
D O I
10.1016/j.cancergencyto.2008.04.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TP53 mutations are observed in about 40-70% of lung cancer tissues, and the hot spot codon mutations are in exons 5 through 8. Previous studies revealed that the distinct TP53 mutational pattern between population groups may be due to different racial or exogenous factors. This research aims to identify risk factors that influence TP53 gene mutation in lung cancer patients residing areas with high lung cancer incidence, in the upper northern part of Thailand. Germline TP53 mutational analyses were also per-formed to determine the inherited cancer predisposition. Exons 5-8 of the TP53 gene were analyzed by sequencing DNA of cancerous tissue and peripheral blood leukocyte samples from 55 non-small lung cell cancer patients. The results showed that the TP53 germline mutation was not found in all patients, indicating that the TP53 germline mutations were not exclusively responsible for cancer predisposition in this group of lung cancer patients. A total of 19 somatic mutations were found in 18 patients. Mutations were predominantly found in exons, with only 10.53% observed at the splice sites of intron 7. No characteristic hot spot codons were observed. The data suggest that TP53 mutations in this study group are induced by exposure to substances other than tobacco smoke. Pesticide exposure or habitation in poorly ventilated houses may instead be related to the tumorigenesis of lung cancer via TP53 mutations. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 37 条
[1]   Pesticides and lung cancer risk in the agricultural health study cohort [J].
Alavanja, MCR ;
Dosemeci, M ;
Samanic, C ;
Lubin, J ;
Lynch, CF ;
Knott, C ;
Barker, J ;
Hoppin, JA ;
Sandler, DP ;
Coble, J ;
Thomas, K ;
Blair, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (09) :876-885
[2]   Relative frequency and morphology of cancers in carriers of germline TP53 mutations [J].
Birch, JM ;
Alston, RD ;
McNally, RJQ ;
Evans, DGR ;
Kelsey, AM ;
Harris, M ;
Eden, OB ;
Varley, JM .
ONCOGENE, 2001, 20 (34) :4621-4628
[3]  
Chunram N, 2007, CHIANG MAI MED J, V46, P1
[4]   TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis [J].
deAnta, JM ;
Jassem, E ;
Rosell, R ;
MartinezRoca, M ;
Jassem, J ;
MartinezLopez, E ;
Monzo, M ;
SanchezHernandez, JJ ;
Moreno, I ;
SanchezCespedes, M .
ONCOGENE, 1997, 15 (24) :2951-2958
[5]  
Deesomchok Athavudh, 2005, Journal of the Medical Association of Thailand, V88, P1236
[6]  
DRACOPOLI NC, 1994, CURRENT PROTOCOLS HU, V2
[7]  
GONG MN, 2002, OCCUPATIONAL DISORDE, P305
[8]   Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment [J].
Hussain, SP ;
Hofseth, LJ ;
Harris, CC .
LUNG CANCER, 2001, 34 :S7-S15
[9]   Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk [J].
Hwang, SJ ;
Lozano, G ;
Amos, CI ;
Strong, LC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (04) :975-983
[10]  
International Agency on Research for Cancer (IARC), TP53 IARC